Accelerating implementation of biomedical research advances

Critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative

Bruce Marshall, Eugene C. Nelson

Research output: Contribution to journalArticle

Abstract

Context: Scientific and therapeutic advances: Remarkable biomedical research advances have led to innovative and increasingly effective therapies. We highlight several scientific milestones in elucidating the pathophysiology of cystic fibrosis (CF) and review the therapies that have become available over the past 20 years. Impact of the quality improvement initiative: In 2002, the CF Foundation launched a multifaceted quality improvement initiative to accelerate improvement in CF care. We present evidence of substantial improvement in process measures, such as more consistent outpatient follow-up, and key medical outcomes, including survival, pulmonary function and nutritional status. Critical success factors: We offer our perspective on factors critical to the success of the quality improvement initiative, including a compelling strategic plan and the commitment of the CF Foundation to its implementation; the investment in building improvement capacity at CF care centres; the engagement of people with CF and their families as partners; and the integration of quality improvement into the existing CF care framework. Directions for the next decade: In addition to a continued investment in building and sustaining improvement capacity at CF care centres, and deeper patient engagement, we will address the oppressive treatment burden. We will also complement the measurement of clinical outcomes with patient reported outcomes and healthcare costs for a balanced assessment of the quality and value of care. Conclusions: Major advances in basic science and therapeutic development coupled with improvements in healthcare delivery have resulted in striking gains in medical outcomes for people with CF.

Original languageEnglish (US)
JournalBMJ Quality and Safety
Volume23
Issue numberSUPPL1
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Cystic Fibrosis
Biomedical Research
Delivery of Health Care
Quality Improvement
Capacity Building
Therapeutics
Patient Participation
Process Assessment (Health Care)
Quality of Health Care
Nutritional Status
Health Care Costs
Outpatients
Lung

ASJC Scopus subject areas

  • Health Policy

Cite this

@article{a06d0628b23b4ab7b46c9781dc93bc04,
title = "Accelerating implementation of biomedical research advances: Critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative",
abstract = "Context: Scientific and therapeutic advances: Remarkable biomedical research advances have led to innovative and increasingly effective therapies. We highlight several scientific milestones in elucidating the pathophysiology of cystic fibrosis (CF) and review the therapies that have become available over the past 20 years. Impact of the quality improvement initiative: In 2002, the CF Foundation launched a multifaceted quality improvement initiative to accelerate improvement in CF care. We present evidence of substantial improvement in process measures, such as more consistent outpatient follow-up, and key medical outcomes, including survival, pulmonary function and nutritional status. Critical success factors: We offer our perspective on factors critical to the success of the quality improvement initiative, including a compelling strategic plan and the commitment of the CF Foundation to its implementation; the investment in building improvement capacity at CF care centres; the engagement of people with CF and their families as partners; and the integration of quality improvement into the existing CF care framework. Directions for the next decade: In addition to a continued investment in building and sustaining improvement capacity at CF care centres, and deeper patient engagement, we will address the oppressive treatment burden. We will also complement the measurement of clinical outcomes with patient reported outcomes and healthcare costs for a balanced assessment of the quality and value of care. Conclusions: Major advances in basic science and therapeutic development coupled with improvements in healthcare delivery have resulted in striking gains in medical outcomes for people with CF.",
author = "Bruce Marshall and Nelson, {Eugene C.}",
year = "2014",
doi = "10.1136/bmjqs-2013-002790",
language = "English (US)",
volume = "23",
journal = "BMJ Quality and Safety",
issn = "2044-5415",
publisher = "BMJ Publishing Group",
number = "SUPPL1",

}

TY - JOUR

T1 - Accelerating implementation of biomedical research advances

T2 - Critical elements of a successful 10 year Cystic Fibrosis Foundation healthcare delivery improvement initiative

AU - Marshall, Bruce

AU - Nelson, Eugene C.

PY - 2014

Y1 - 2014

N2 - Context: Scientific and therapeutic advances: Remarkable biomedical research advances have led to innovative and increasingly effective therapies. We highlight several scientific milestones in elucidating the pathophysiology of cystic fibrosis (CF) and review the therapies that have become available over the past 20 years. Impact of the quality improvement initiative: In 2002, the CF Foundation launched a multifaceted quality improvement initiative to accelerate improvement in CF care. We present evidence of substantial improvement in process measures, such as more consistent outpatient follow-up, and key medical outcomes, including survival, pulmonary function and nutritional status. Critical success factors: We offer our perspective on factors critical to the success of the quality improvement initiative, including a compelling strategic plan and the commitment of the CF Foundation to its implementation; the investment in building improvement capacity at CF care centres; the engagement of people with CF and their families as partners; and the integration of quality improvement into the existing CF care framework. Directions for the next decade: In addition to a continued investment in building and sustaining improvement capacity at CF care centres, and deeper patient engagement, we will address the oppressive treatment burden. We will also complement the measurement of clinical outcomes with patient reported outcomes and healthcare costs for a balanced assessment of the quality and value of care. Conclusions: Major advances in basic science and therapeutic development coupled with improvements in healthcare delivery have resulted in striking gains in medical outcomes for people with CF.

AB - Context: Scientific and therapeutic advances: Remarkable biomedical research advances have led to innovative and increasingly effective therapies. We highlight several scientific milestones in elucidating the pathophysiology of cystic fibrosis (CF) and review the therapies that have become available over the past 20 years. Impact of the quality improvement initiative: In 2002, the CF Foundation launched a multifaceted quality improvement initiative to accelerate improvement in CF care. We present evidence of substantial improvement in process measures, such as more consistent outpatient follow-up, and key medical outcomes, including survival, pulmonary function and nutritional status. Critical success factors: We offer our perspective on factors critical to the success of the quality improvement initiative, including a compelling strategic plan and the commitment of the CF Foundation to its implementation; the investment in building improvement capacity at CF care centres; the engagement of people with CF and their families as partners; and the integration of quality improvement into the existing CF care framework. Directions for the next decade: In addition to a continued investment in building and sustaining improvement capacity at CF care centres, and deeper patient engagement, we will address the oppressive treatment burden. We will also complement the measurement of clinical outcomes with patient reported outcomes and healthcare costs for a balanced assessment of the quality and value of care. Conclusions: Major advances in basic science and therapeutic development coupled with improvements in healthcare delivery have resulted in striking gains in medical outcomes for people with CF.

UR - http://www.scopus.com/inward/record.url?scp=84896520923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896520923&partnerID=8YFLogxK

U2 - 10.1136/bmjqs-2013-002790

DO - 10.1136/bmjqs-2013-002790

M3 - Article

VL - 23

JO - BMJ Quality and Safety

JF - BMJ Quality and Safety

SN - 2044-5415

IS - SUPPL1

ER -